National Institutes of Health: Gastrointestinal Diseases trials

The registry lists 10 Gastrointestinal Diseases studies with National Institutes of Health as lead sponsor. 1 are open to participants now and 0 have results posted.

Phase 1 2Phase 2 2Phase 3 2No phase 4(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Evaluation of Patients With Gastrointestinal DiseaseRecruitingNCT05041374
• Sirolimus for Eosinophil-Associated Gastrointestinal DisordersTerminatedNCT01814059Phase 1
• Evaluation of People With Gastrointestinal DiseaseCompletedNCT01639924
• Immunopathogenesis of Food Allergy and Eosinophilic Gastrointestinal DisordersTerminatedNCT01212016
• A Trial of Tap Water Treatment in the ElderlyCompletedNCT00058942Not applicable
• Treatment of Functional Bowel DisordersCompletedNCT00006157Phase 3
• Phase II Pilot Study to Compare the Bioavailability of Buffered, Enteric-Coated Ursodiol With Unmodified Ursodiol for Chronic Cholestatic Liver Disease and Cystic Fibrosis-Associated Liver DiseaseStatus unknownNCT00004315Phase 2
• A Randomized, Double-Blind, Placebo Controlled Trial Evaluating the Impact of Nystatin on the Development of Oral Irritation in Patients Receiving High Dose Intravenous Interleukin-2CompletedNCT00001812Phase 3
• The Safety and Effectiveness of Ganciclovir in the Prevention of Cytomegalovirus (CMV) of the Eyes and Disease of the Stomach and Intestines in Patients With HIVCompletedNCT00001034Phase 2
• A Randomized Comparative Pharmacokinetic Study of Oral Ganciclovir After Treatment With Intravenous Ganciclovir for Cytomegalovirus Gastrointestinal Disease in AIDS PatientsCompletedNCT00000768Phase 1